Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bloodbuy
AddedFeb 16, 2024
UpdatedJun 18, 2026
Bloodbuy

Bloodbuy

Acquired

Healthcare tech firm, Bloodbuy, optimizes blood distribution between hospitals and blood centers.

HQ
Dallas, TX, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to optimize the distribution of lifesaving blood products, Bloodbuy is a healthcare technology company that connects hospitals and blood centers through its innovative digital platform. The company's core vision is to ensure that blood products are efficiently and effectively distributed where they are needed most, reducing waste and improving patient outcomes. Bloodbuy operates primarily in the United States, Europe, and the Caribbean, serving a wide range of healthcare institutions.

Notable affiliated individuals include key healthcare professionals and technology experts who have driven the company's growth and innovation. Bloodbuy has garnered significant attention from investors focused on healthcare technology, contributing to its rapid expansion and adoption. The company has achieved critical milestones in enhancing the efficiency of blood distribution networks, thereby having a substantial impact on public health and emergency medical services.

Bloodbuy - Similar Companies

HemaVista logo

HemaVista

Secure Transfusion Services logo

Secure Transfusion Services

Blood Monitoring Solutions logo

Blood Monitoring Solutions

Haemonetics logo

Haemonetics

haemonetics.com

Wala Digital Health logo

Wala Digital Health

waladigital.io

B Positive Plasma logo

B Positive Plasma

bpositivetoday.com

Phlebx logo

Phlebx

phlebx.com

Sanguis logo

Sanguis

sanguiswine.com

BloodQ logo

BloodQ

bloodq.com

Innovative Trauma Care logo

Innovative Trauma Care

FloBio logo

FloBio

flobiollc.com

Hemobiotech logo

Hemobiotech

Coagulation Sciences logo

Coagulation Sciences

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Velico Medical logo

Velico Medical

veli.co

Bloodbuy - Quick Facts

Who are Bloodbuy's competitors?

Companies similar to Bloodbuy include HemaVista, Secure Transfusion Services, Blood Monitoring Solutions and Haemonetics.

When was Bloodbuy founded?

Bloodbuy was founded in 2015.

Where is Bloodbuy's headquarters located?

Bloodbuy's headquarters is located in Dallas, TX, US.

When was Bloodbuy's last funding round?

Bloodbuy's most recent funding round was for $3.8M (USD) in February 2016.

How much has Bloodbuy raised to-date?

As of Feb 17, 2016, Bloodbuy has raised a total of $3.8M (USD).

Bloodbuy - Classification

Industry
  • Hospitals
Ownership
  • Venture Capital
Technology
  • Technology
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Transactional
Main Product
  • Blood Distribution
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
  • 7372Prepackaged Software